Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.
AUTOR(ES)
Balogh, Z
RESUMO
Total plasma zinc levels in patients with rheumatoid arthritis on different therapeutic treatments were determined in conjunction with total serum proteins, serum albumin and globulin, and articular index of joint tenderness, erythrocyte sedimentation rate, rheumatoid factor, serum copper, and serum iron. There were significantly lower zinc levels in patients with rheumatoid arthritis on nonsteroidal anti-inflammatory drugs than in patients on levamisole and penicillamine. Zinc levels correlated positively with serum albumin, and there was an inverse correlation between zinc levels and both ESR and globulin concentration in all rheumatoid patients. However, the correlation coefficient varied in the different treatment groups. The results of this study support the hypothesis that low plasma zinc level in rheumatoid arthritis is one of the nonspecific features of inflammation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000551Documentos Relacionados
- Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.
- Proceedings: Plasma zinc in rheumatoid arthritis. Its relationship to corticosteroid therapy and osteoporosis.
- Proceedings: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices.
- Relationship of radiological change to clinical outcome in rheumatoid arthritis.
- Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function.